Seeing Machines Limited · LSE:SEE
Seeing Machines — Non-Deal Roadshow (September 2007)
23 slides from Seeing Machines's roadshow presentation, September 2007
Slide 1: Seeing Machines Limited
Seeing Machines Limited AIM:SEE www.seeingmachines.com September 2007 sm10677-4
Slide 2: Overview
Overview Value Unique technology enables solutions and products that would be impossible otherwise proposition Our technology products will save lives and help preserve people’s vision, reducing their huge economic impacts Our software products help clients build their products/do their work f
Slide 3: Company evolution
Company evolution Four broad phases Pre-IPO status: up to Dec 2005 • 1997-2000: “Research collaboration” • Company formed July 2000 • ~£5m invested in technology/product development • £1.4m government R&D funding • 2000 – 2005: “Technology Development” • £1.5m periodic private funding rounds - launc
Slide 4: Overview of recent product deliverables
Overview of recent product deliverables Last 18 months Development of new product lines: TrueField Analyzer (TFA) , Driver State Sensor (DSS) (following IPO) and API (application programming interface). Consolidation of existing product base: faceLAB Building foundation for profitability: thro
Slide 5: Products & underlying technology
Products & underlying technology Human Factors - Technology Demonstrator Automotive Devices - Prototyping tool - Driver fatigue & distraction - Driver assistance API Licensing - Head, eye tracking - Sports training products - Computer gaming and entertainment - Biometric security - Robotics Head, Ey
Slide 6: Our computer vision technologies
Our computer vision technologies Key focus To be the world-leader in providing computer vision processing technologies, especially related to naturalistic human – machine interaction Core Seeing Machines specializes in enabling computer systems and applications to: capabilities Find faces & spec
Slide 7: Competitive Position
Competitive Position Market Ready Revolutionary vision testing technology demonstrated in extensive clinical study program Simultaneous measurement of head pose / eye gaze - a key innovation Consistently outranked competitors in auto-maker analysis & technology selection Our vision processin
Slide 8: Healthcare
Healthcare Seeing Machines technology enables new methods/devices for detecting and managing diseases of the human visual system and some neurological conditions Goal To generate strong royalty streams from devices that utilize Seeing Machines’ objective visual field testing capability ANU Exclu
Slide 9: What do glaucoma sufferers experience?
What do glaucoma sufferers experience? Seeing Machines 2007: sm10677-4 Page 9
Slide 10: Healthcare
Healthcare TFA initial Initially a complement to existing SAP - Eventually a replacement for SAP markets 70–150k ophthalmologists globally, Optometrist numbers 5+ times Typically replace equipment every ~7 yrs TFA channels In serious dialog with four major ophthalmic device OEM companies F
Slide 11: faceLAB
faceLAB Product A demonstrator product embodying our core vision processing capabilities overview Launched May 2001 and achieved over £4.1 million in sales revenue to June 07 (A$9.9m) Four major generations of the product Primary portion of current sales revenue Users Sold to “Human Factor
Slide 12: faceLAB – recent product developments
faceLAB – recent product developments Scene Camera See what the user was looking at! Plots user gaze/view direction into video of scene captured in real time faceLAB-LINK Join multiple faceLAB systems together! Unlimited tracking range / field of view giving great flexibility Seeing Machines 2007:
Slide 13: Automotive & Transport
Automotive & Transport Seeing Machines technology enables the next generation of transport safety systems and devices … Goals Near term: to generate strong product revenues from low/medium volume sales of single-board computer systems to fleet, mining and long haul freight operators. Long term:
Slide 14: Automotive & Transport
Automotive & Transport OEM Driver SM long term goal has been high volume DSS deployment into OEM new vehicles Assistance Lexus brought 1st system to market 2006 & put significant pressure on all brands Systems Consumer & OEM market for driver assistance systems is maturing Our DSS technology
Slide 15: API (application programming interface)
API (application programming interface) Seeing Machines tracking software is a key enabling technology for many 3rd party applications Goal To generate strong licensing revenue through deployment of Seeing Machines’ core tracking technology to 3rd party applications and products Applications Ext
Slide 16: Current position
Current position New products: faceLAB v4.5 (July 2007) – delivers real market advantages, good sales and prospects. aggressive DSS2 (July 2007) – Independently rated #1 technology, great startup sales and prospects development TrueField Analyzer - exciting pre-production position with good ne
Slide 17: Directors
Directors Highly credentialed mix of technical, financial and commercial skills at both Board and Management level: Fulton Muir AO Chairman. Chair of ANU Enterprise, former Chair of ANU Finance Committee, long and distinguished banking career. Awarded Order of Australia in 1992. Dr Nick Cerneaz CEO;
Slide 18: Key Management
Key Management Dr Nick Cerneaz CEO; see previous page Dr Jochen Heinzmann Co-founder and Principal Researcher, Automotive. Computer vision expert involved in creation & development of Company’s technology. Dr Sebastien Rougeaux Co-founder and Principal Researcher, Medical. Robotics and computer visi
Slide 19: Financial Goals
Financial Goals Revenue Continue to generate consistent revenues from faceLAB and established API deals Exploit the recently launched DSS2 commercial product through building extensive new sales. Leverage existing faceLAB distribution channels to keep costs low and gain widespread market access.
Slide 20: Use of funds
Use of funds TrueField Analyzer commercialization £650,000 $1,540,500 DSS2 commercialization £150,000 $355,500 faceLAB and API market development £420,000 $995,400 Working capital £60,000 $142,200 Costs of raising £120,000 $284,400 Totals £1,400,000 $3,318,000 AUD:GBP exchange rate = 2.37 Seeing Ma
Slide 21: Current Capital Structure
Current Capital Structure PERCENTAGE OF SHAREHOLDER NUMBER OF SHARES TOTAL SHARES IN ISSUE JATS Technology Pty Ltd 85,594,176 33.41% Australian National University 28,114,687 10.98% Volvo Technological Development 23,226,073 9.07% Pershing Keen Nominees Limited 10,916,642 4.26% Pershing Keen Nominee
Slide 22: Other references
Other references For more detailed information about Seeing Machines and its technology and markets, see: www.seeingmachines.com Disclaimer This document is confidential to Seeing Machines Limited. The recipient of this document must not distribute, copy, broadcast or extract any information contain
Slide 23: Thank-you
Thank-you www.seeingmachines.com Seeing Machines 2007: sm10677-4 Page 23